Home
Market Capitalization of Eris Lifesciences Ltd

ERIS Lifesciences Ltd
NSE: ERIS
Market Cap
Key Highlights
- The Market Cap of ERIS Lifesciences Ltd is ₹ 17422 crore as of 21 Feb 25 .
- The Latest Trading Price of ERIS Lifesciences Ltd is ₹ 1279 as of 21 Feb 15:30 .
- The dividend payouts of ERIS Lifesciences Ltd changed from ₹ 2.87 to ₹ 7.35 over 5 quarters. This represents a CAGR of 112.19% .

ERIS Lifesciences Ltd
NSE: ERIS
Share Price
Market Price of ERIS Lifesciences Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 1279.85 |
20 Feb 2025 | 1273.15 |
19 Feb 2025 | 1281.1 |
18 Feb 2025 | 1251.4 |
17 Feb 2025 | 1251.5 |
14 Feb 2025 | 1250.55 |
13 Feb 2025 | 1264.55 |
12 Feb 2025 | 1301.85 |
11 Feb 2025 | 1334.8 |
10 Feb 2025 | 1406.8 |
SWOT Analysis Of ERIS Lifesciences Ltd
BlinkX Score for ERIS Lifesciences Ltd
Asset Value vs Market Value of ERIS Lifesciences Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of ERIS Lifesciences Ltd
Historical P/E Ratio of ERIS Lifesciences Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of ERIS Lifesciences Ltd
Historical Revenue of ERIS Lifesciences Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of ERIS Lifesciences Ltd
Historical EBITDA of ERIS Lifesciences Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of ERIS Lifesciences Ltd
Historical Net Profit of ERIS Lifesciences Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of ERIS Lifesciences Ltd
Historical Dividend Payouts of ERIS Lifesciences Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payouts of ERIS Lifesciences Ltd
About ERIS Lifesciences Ltd
- Eris Lifesciences Limited was incorporated on January 25, 2007.
- Subsequently, the name of the company was changed to 'Eris Lifesciences Private Limited' on February 9, 2007.
- Further, the Company was converted into a Public Limited cCompany and the name was changed to 'Eris Lifesciences Limited' on February 2, 2017.
- The Company has a manufacturing plant in Guwahati, Assam and is presently engaged in manufacturing and marketing of pharmaceutical products.
- It has presence in high growth chronic, sub chronic and acute therapeutic areas that require high intervention of specialist and super specialist doctors.
ERIS Lifesciences Ltd News Hub
ERIS Lifesciences to convene AGM
ERIS Lifesciences announced that the 18th Annual General Meeting (AGM) of the company will be held o
Read more
05 Aug 24
ERIS Lifesciences consolidated net profit declines 12.31% in the June 2024 quarter
Net profit of ERIS Lifesciences declined 12.31% to Rs 83.18 crore in the quarter ended June 2024 as
Read more
02 Aug 24
ERIS Lifesciences announces board meeting date
ERIS Lifesciences will hold a meeting of the Board of Directors of the Company on 25 October 2024. P
Read more
22 Oct 24
ERIS Lifesciences to hold board meeting
ERIS Lifesciences will hold a meeting of the Board of Directors of the Company on 4 February 2025. P
Read more
29 Jan 25